Home/Filings/4/0001615219-23-000023
4//SEC Filing

Arthur David J. 4

Accession 0001615219-23-000023

CIK 0001615219other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:04 PM ET

Size

6.3 KB

Accession

0001615219-23-000023

Insider Transaction Report

Form 4
Period: 2023-02-13
Arthur David J.
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-02-13+14,30048,019 total
Holdings
  • Common Stock

    (indirect: By son)
    564
  • Common Stock

    (indirect: By daughter)
    552
Footnotes (1)
  • [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc. 2015 Equity Incentive Plan in lieu of cash for performance bonus. The shares of common stock are subject to a six-month holding period pursuant to the terms of the restricted stock agreement.

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001769331

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:04 PM ET
Size
6.3 KB